Impact of Toll-Like Receptor 2 and 9 Gene Polymorphisms on COVID-19: Susceptibility, Severity, and Thrombosis

References

• Al-Tawfiq JA, Petersen E, Memish ZA, Perlman S, Zumla A. Middle East respiratory syndrome coronavirus—The need for global proactive surveillance, sequencing, and modeling. Travel Med Infect Dis. 2021;43:102118. doi:10.1016/j.tmaid.2021.102118
   Web of Science ®Google Scholar
• Ghosh S, Dellibovi-Ragheb TA, Kerviel A, et al. ß-coronaviruses use lysosomes for egress instead of the biosynthetic secretory pathway. Cell. 2020;183(6):1520–1535.e14. doi:10.1016/j.cell.2020.10.039
   PubMed Web of Science ®Google Scholar
• Oliveira-Nascimento L, Massari P, Wetzler LM. The role of TLR2 in infection and immunity. Front Immunol. 2012;18(3):79. doi:10.3389/fimmu.2012.00079
   Google Scholar
• Sariol A, Perlman S. SARS-COV-2 takes its Toll. Nat Immunol. 2021;22:801–802. doi:10.1038/s41590-021-00962-w
   Web of Science ®Google Scholar
• Zheng M, Karki R, Williams EP, et al. TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines. Nat Immunol. 2021;22:829–838. doi:10.1038/s41590-021-00937-x
   PubMed Web of Science ®Google Scholar
• El Kebir D, Damlaj A, Makhezer N, Filep JG. Toll-like receptor-9 signaling regulates tissue factor and tissue factor pathway inhibitor expression in human endothelial cells and coagulation in mice. Crit Care Med. 2015;43(6):e179–e189. doi:10.1097/CCM.0000000000001005
   Web of Science ®Google Scholar
• Bezemer GPG, Garssen J. TLR9 and COVID-19: a multidisciplinary theory of a multifaceted therapeutic target. Front Pharmacol. 2021;11:601685. doi:10.3389/fphar.2020.601685
   Web of Science ®Google Scholar
• Fuchs TA, Brill A, Duerschmied D, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A. 2010;107(36):15880–15885. doi:10.1073/pnas.1005743107
   PubMed Web of Science ®Google Scholar
• Barnes BJ, Adrover JM, Baxter-Stoltzfus A, et al. Targeting potential drivers of COVID-19: neutrophil extracellular traps. J Exp Med. 2020;217(6):e20200652. doi:10.1084/jem.20200652
   PubMed Web of Science ®Google Scholar
• Itagaki K, Kaczmarek E, Lee YT, et al. Mitochondrial DNA released by trauma Induces neutrophil extracellular traps. PLoS One. 2015;10(3):e0120549. doi:10.1371/journal.pone.0120549
   Web of Science ®Google Scholar
• Schellekens GA, Visser H, de Jong BA, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000;43(1):155–163. doi:10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3
   PubMed Web of Science ®Google Scholar
• Sung PS, Hsieh SL. CLEC2 and CLEC5A. Pathogenic host factors in acute viral infections. Front Immunol. 2019;10:2867. doi:10.3389/fimmu.2019.02867
   PubMed Web of Science ®Google Scholar
• Sung P, Yang S, Peng Y, Sun C, Tao M, Hsieh S. CLEC5A and TLR2 a 1 re critical in SARS-CoV-2-induced NET formation and lung inflammation. J Biomed Sci. 2022;29:52. doi:10.1186/s12929-022-00832-z
   Web of Science ®Google Scholar
• Taha SI, Shata AK, Baioumy SA, et al. Toll-like receptor 4 polymorphisms (896A/G and 1196C/T) as an indicator of COVID-19 severity in a convenience sample of Egyptian patients. J Inflamm Res. 2021;14:6293–6303. doi:10.2147/JIR.S343246
   PubMed Web of Science ®Google Scholar
• Khandia R, Pandey MK, Khan AA, Rzhepakovsky IV, Gurjar P, Karobari MI. Codon usage and context analysis of genes modulated during SARS-CoV-2. Infection and dental inflammation. Vaccines. 2022;10(11):1874. doi:10.3390/vaccines10111874
   Web of Science ®Google Scholar
• Hill AV. The genomics and genetics of human infectious disease susceptibility. Annu Rev Genomics Hum Genet. 2001;2:373–400. doi:10.1146/annurev.genom.2.1.373
   PubMed Web of Science ®Google Scholar
• Alseoudy MM, Elgamal M, Abdelghany DA, et al. Prognostic impact of toll-like receptors gene polymorphism on outcome of COVID-19 pneumonia: a case-control study. Clin Immunol. 2022;235:108929. doi:10.1016/j.clim.2022.108929
   Web of Science ®Google Scholar
• World Health Organization. Coronavirus disease (COVID-19) weekly epidemiological update and weekly operational update; 2019. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed February 9, 2023.
   Google Scholar
• Bai HX, Hsieh B, Xiong Z, et al. Performance of radiologists in differentiating COVID 19 from viral pneumonia on chest CT. Radiology. 2020;296(2):E46–E54. doi:10.1148/radiol.2020200823
   PubMed Web of Science ®Google Scholar
• Akira S. Toll-like receptor signaling. J Biol Chem. 2003;278(40):38105–38108. doi:10.1074/jbc.r300028200
   PubMed Web of Science ®Google Scholar
• Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004;16(1):3–9. doi:10.1016/j.smim.2003.10.003
   PubMed Web of Science ®Google Scholar
• Pasare C, Medzhitov R. Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol. 2005;560:11–18. doi:10.1007/0-387-24180-9_2
   PubMed Web of Science ®Google Scholar
• Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA, Tuomanen EI. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immunol. 2000;68:6398–6401. doi:10.1128/IAI.68.11.6398-6401.2000
   PubMed Web of Science ®Google Scholar
• Ogus AC, Yoldas B, Ozdemir T, et al. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur Respir J. 2004;23(2):219–223. doi:10.1183/09031936.03.00061703
   Web of Science ®Google Scholar
• Schroder NW, Diterich I, Zinke A, et al. Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late-stage Lyme disease. J Immunol. 2005;175:2534–2540. doi:10.4049/jimmunol.175.4.2534
   PubMed Web of Science ®Google Scholar
• Kijpittayarit S, Eid AJ, Brown RA, Paya CV, Razonable RR. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin Infect Dis. 2007;44:1315–1320. doi:10.1086/514339
   PubMed Web of Science ®Google Scholar
• Tabel Y, Berdeli A, Mir S. Association of TLR2 gene Arg753Gln polymorphism with urinary tract infection in children. Int J Immunogenet. 2007;34:399–405. doi:10.1111/j.1744-313X.2007.00709.x
   Web of Science ®Google Scholar
• Berdeli A, Celin HA, Ozyurek R, Dogrusoz B, Aydin HH. TLR-2 gene Arg753Gln polymorphism is strongly associated with acute rheumatic fever in children. J Mol Med. 2005;83:535–541. doi:10.1007/s00109-005-0677-x
   PubMed Web of Science ®Google Scholar
• Kutukculer N, Yeniay BS, Aksu G, Berdeli A. Arg753Gln polymorphism of the human toll-like receptor-2 gene in children with recurrent febrile infections. Biochem Genet. 2007;45:507–514. doi:10.1007/s10528-007-9091-0
   Web of Science ®Google Scholar
• Ozen S, Berdeli A, Turel B, et al. Arg753Gln TLR-2 polymorphism in familial Mediterranean fever: linking the environment to the phenotype in a monogenic inflammatory disease. J Rheumatol. 2006;33:2498–2500. PMID: 17013994.
   Web of Science ®Google Scholar
• El-Nabi SH, Sayed S, Abd-Elhafez MA, Elfiky M, Abdel Moneim AE, El-Garawani I. Arg753Gln polymorphisms in the TLR2 gene are associated with cytomegalovirus infection in Egyptian bone marrow recipients. Endocr Metab Immune Disord Drug Targets. 2020;20(4):619–624. doi:10.2174/1871530319666191018124710
   Web of Science ®Google Scholar
• Park Y, Park S, Yoo E, Kim D, Shin H. Association of the polymorphism for Toll-like receptor 2 with type 1 diabetes susceptibility. Ann N Y Acad Sci. 2004;1037:170–174. doi:10.1196/annals.1337.028
   PubMed Web of Science ®Google Scholar
• Hamann L, Gomma A, Schroder NW, et al. A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis. J Mol Med. 2005;83:478–485. doi:10.1007/s00109-005-0643-7
   PubMed Web of Science ®Google Scholar
• Eid AJ, Brown RA, Paya CV, Razonable RR. Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation. 2007;84:511–516. doi:10.1097/01.tp.0000276960.35313.bf
   Web of Science ®Google Scholar
• Akira S, Hemmi H. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett. 2003;85(2):85–95. doi:10.1016/s0165-2478(02)00228-6
   PubMed Web of Science ®Google Scholar
• Ng MTH, Van’t Hof R, Crockett JC, et al. Increase in NF-κB binding affinity of the variant C allele of the toll-like receptor 9 −1237T/C polymorphism Is associated with Helicobacter pylori induced gastric disease. Infect Immun. 2010;78(3):1345–1352. doi:10.1128/iai.01226-09
   PubMed Web of Science ®Google Scholar
• Chatzi M, Papanikolaou J, Makris D, et al. Toll-like receptor 2, 4 and 9 polymorphisms and their association with ICU-acquired infections in Central Greece. J Crit Care. 2018;47:1–8. doi:10.1016/j.jcrc.05.012
   Web of Science ®Google Scholar
• Carvalho A, Osorio NS, Saraiva M, et al. The C allele of rs5743836 polymorphism in the human TLR9 promoter links IL-6 and TLR9 up-regulation and confers Increased B-cell proliferation. PLoS One. 2011;6(11):e28256. doi:10.1371/journal.pone.0028256
   PubMed Web of Science ®Google Scholar
• Elsherif RH, Algebaly HAF, Ismail DK, et al. Toll-like receptors 2 and 9 gene polymorphisms in severe sepsis and septic shock: a single center study in the pediatric intensive care unit. Int J Clin Exp Med. 2019;12(4):4381–4386.
   Web of Science ®Google Scholar
• Lazarus R, Klimecki WT, Raby BA, et al. Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case–control disease association studies. Genomics. 2003;81:85–91. doi:10.1016/s0888-7543(02)00022-8
   PubMed Web of Science ®Google Scholar
• Torok HP, Glas J, Tonenchi L, Bruennler G, Folwaczny M, Folwaczny C. Crohn’s disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology. 2004;127:365–366. doi:10.1053/j.gastro.2004.05.051
   PubMed Web of Science ®Google Scholar
• Ng MTW, Lau CS, Chan TM, Wong WH, Lau YL. Polymorphisms of the toll-like receptor 9 (TLR9) gene with systemic lupus erythematosus in Chinese. Rheumatology. 2005;44:1456–1457. doi:10.1093/rheumatology/kei120
   PubMed Web of Science ®Google Scholar
• Delanghe JR, De Buyzere ML, Speeckaert MM. Genetic polymorphisms in the host and COVID-19 infection. Adv Exp Med Biol. 2021;1318:109–118. doi:10.1007/978-3-030-63761-3_7
   Web of Science ®Google Scholar
• Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812–827.e19. doi:10.1016/j.cell.2020.06.043
   PubMed Web of Science ®Google Scholar
• Kumar BK, Rohit A, Prithvisagar KS, Rai P, Karunasagar I, Karunasagar I. Deletion in the C-terminal region of the envelope glycoprotein in some of the Indian SARS-CoV-2 genome. Virus Res. 2021;291:198222. doi:10.1016/j.virusres.2020.198222
   Web of Science ®Google Scholar
• Shen L, Bard JD, Triche TJ, Judkins AR, Biegel JA, Gai X. Emerging variants of concern in SARS-CoV-2 membrane protein: a highly conserved target with potential pathological and therapeutic implications. Emerg Microbes Infect. 2021;10(1):885–893. doi:10.1080/22221751.2021.1922097
   PubMed Web of Science ®Google Scholar
• Singh A, Steinkellner G, K¨ochl K, Gruber K, Gruber CC. Serine 477 plays a crucial role in the interaction of the SARS-CoV-2 spike protein with the human receptor ACE2. Sci Rep. 2021;11(1):1–11. doi:10.1038/s41598-021-83761-5
   PubMed Web of Science ®Google Scholar
• Ortuso F, Mercatelli D, Guzzi PH, Giorgi FM. Structural genetics of circulating variants affecting the SARS-CoV-2 spike/human ACE2 complex. J Biomol Struct Dyn. 2021;1–11. doi:10.1080/07391102.2021.1886175
   Web of Science ®Google Scholar
• Thålin C, Daleskog M, Göransson SP, et al. Validation of an enzyme-linked immunosorbent assay for the quantification of citrullinated histone H3 as a marker for neutrophil extracellular traps in human plasma. Immunol Res. 2017;65(3):706–712. doi:10.1007/s12026-017-8905-3
   PubMed Web of Science ®Google Scholar